Before prescribing ONTRUZANT, please read the accompanying
Prescribing Information, including the Boxed Warning about cardiomyopathy,
infusion reactions (pulmonary toxicity), and embryo-fetal toxicity.
THE ORGANON CO-PAY ASSISTANCE PROGRAM
The Organon Co-pay Assistance Program offers assistance to eligible patients who need help affording ONTRUZANT.
- Once enrolled, eligible, privately insured patients pay the first $5 of their co-pay per infusion
- Maximum co-pay assistance program benefit is $25,000 per patient, per calendar year
Co-pay assistance from the Organon Co-pay Assistance Program is not insurance. Restrictions apply. See Terms and Conditions.
- Are a resident of the United States
- Have private health insurance that provides coverage for ONTRUZANT under a medical benefit program
- Have been prescribed ONTRUZANT for an FDA-approved indication
- Meet all other Terms and Conditions of the program
The Organon Co-pay Assistance Program is not valid for patients covered under a Government Program, as that term is defined in the Terms and Conditions. The Organon Co-pay Assistance Program is not valid for uninsured patients.
Patient and health care professional must submit all required information. Please see the enrollment form for details.
Other financial support options
What if my patient isn't eligible for the Organon Co-pay Assistance Program?
Your patient may be able to get help from an independent co-pay assistance foundation. A representative can provide you with information about independent foundations that may be able to provide financial support to patients who do not qualify for the Organon Co-pay Assistance Program. Each independent foundation has its own eligibility criteria and application process.
